Clinical Trials
Phesi analysis shows difference of up to three months...
Analysis from virtual clinical development specialist Phesi shows the enrollment and effectiveness of two current COVID-19 vaccine trials conducted by global pharmaceutical development companies. On...
News
RDIF and Uniao Quimica file documents for registration of...
The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund), União QuÃmica Farmacêutica Nacional and the Government of the State of Paraná announce the pre-submission...
Clinical Trials
Tiziana begins study of nasally administered Foralumab either alone...
Tiziana Life Sciences, a biotechnology company, announced initiation of a collaborative clinical study investigating nasally administered Foralumab either alone or in combination with orally administered...
News
BERG Creates Collaborative Healthcare Model to Transform the Future...
Partners across multiple healthcare divisions join forces to break down siloes to accelerate precision medicine opportunities for COVID-19 and beyond BERG, a clinical-stage biotech that...
Clinical Trials
Mayo Clinic Collaborates with Vocalis Health for Clinical Development...
Mayo Clinic and Vocalis Health, Inc., a company pioneering AI-based vocal biomarkers for use in healthcare, announced a collaboration to research and develop new voice-based...
Clinical Trials
Bimekizumab Phase 3 Data Shows Superior Skin Clearance Over...
UCB, a global biopharmaceutical company, announced the detailed results of the head-to-head Phase 3 BE SURE study, which demonstrated that patients treated with investigational IL-17A...
News
EC approves Roches Tecentriq in combination with Avastin for...
Roche announced that the European Commission has approved Tecentriq® (atezolizumab) in combination with Avastin® (bevacizumab) for the treatment of adult patients with advanced or unresectable...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.